Detalles de la búsqueda
1.
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages.
Cancer Immunol Immunother;
72(6): 1789-1801, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36656341
2.
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
Cancer Immunol Immunother;
67(6): 861-872, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500635
3.
Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients.
Front Oncol;
11: 622896, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34094908
4.
Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A.
Front Immunol;
9: 2848, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30564241
5.
NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.
Front Immunol;
9: 1415, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29988376
6.
A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism.
Sci Rep;
8(1): 15983, 2018 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30374078
7.
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human.
Clin Cancer Res;
24(4): 766-776, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233904
8.
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma.
J Extracell Vesicles;
22013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24223258
Resultados
1 -
8
de 8
1
Próxima >
>>